The overall rating for chamomile is 3 out of 3 meaning there is evidence that this supplement lives up to its expectations. Using this supplement should lead to positive results.
- Simple Report
- Detailed Report
- Overall Effectiveness Rating
- Research Rating
- Products Containing Chamomile
- Claim Ratings
Overall Effectiveness Rating
The overall effectiveness rating for chamomile is 3 out of 3. This rating means the evidence is clear on the supplement's ability to deliver positive results. Using this supplement will lead to positive results. Note, this effectiveness rating is for chamomile as a whole; there are also individual ratings for the claims below.
Read more: What is the effectiveness rating?
Research Rating for Chamomile
There is one study in the database on chamomile; the research rating is 20. A score above 80 means the effectiveness rating for this supplement is reliable. A score under 80 means there is insufficient evidence to ensure a reliable effectiveness rating. Note, this research rating is for chamomile as a whole; there are also individual ratings for the claims below.
Read more: What is the research rating?
Products Containing Chamomile
|Products Names||Amount of Chamomile|
|I Want To Sleep||80mg|
|Rack OPS||Amount not listed.|
|OxyREM for Women||60mg|
|Full list of all 31 products containing Chamomile.|
The overall ratings above are an average of the individual claim ratings below. Individual claims may have higher or lower ratings compared to the supplement's overall rating. For example, some supplements may have excellent backing for one claim, but be completely useless for another. Click on a claim below for more information.
|Recovery Claims||Effectiveness Rating||Research Rating|
|reduce joint pain|
The Supplement Database includes 1 studies on chamomile dosing. These studies indicate an effective dose is 6 grams per day. For a more detailed dosing analysis visit: Supplement Dosing for Chamomile.
|Title of Study|
|The effect of chamomile tea consumption on inflammation among rheumatoid arthritis patients: randomized clinical trial|